Pilot Study of Local Cryotherapy for Treating Unresectable Recurrent Head and Neck Cancer in Previously Irradiated Areas

What this Trial Is About

Researchers are evaluating local cryotherapy as a treatment for recurrent head and neck cancers located in previously irradiated areas. This pilot study focuses on patients with unresectable locoregional recurrences, who have limited treatment options and poor survival rates. Traditional treatments like surgery and radiochemotherapy have limited success or cause significant toxicity, creating a need for alternative therapies with better safety and effectiveness profiles. Participants will receive local cryotherapy treatment, a minimally invasive technique that uses extreme cold to destroy cancer tissues. This procedure is being studied as a potential alternative to re-irradiation or surgery for tumors that cannot be removed. The study aims to assess the local tumor control rate at 12 months after treatment and monitor any complications or adverse events related to cryotherapy. During the study, patients will be closely monitored with assessments of tumor control at 6 and 12 months, evaluation of any side effects, and quality of life questionnaires at 1, 3, 6, and 12 months post-treatment. The research team will track patients overall health, kidney function, and other safety factors. Participation includes follow-up visits to measure outcomes and ensure patient well-being throughout the study period.

Evaluation of the Efficacy and Safety of Local Cryotherapy Treatment of Recurrent Head and Neck Cancer in Irradiated Areas: a Pilot Study